Fengbin Liu

1.1k total citations
53 papers, 807 citations indexed

About

Fengbin Liu is a scholar working on Complementary and alternative medicine, Gastroenterology and Surgery. According to data from OpenAlex, Fengbin Liu has authored 53 papers receiving a total of 807 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Complementary and alternative medicine, 15 papers in Gastroenterology and 13 papers in Surgery. Recurrent topics in Fengbin Liu's work include Traditional Chinese Medicine Studies (15 papers), Gastrointestinal motility and disorders (12 papers) and Helicobacter pylori-related gastroenterology studies (11 papers). Fengbin Liu is often cited by papers focused on Traditional Chinese Medicine Studies (15 papers), Gastrointestinal motility and disorders (12 papers) and Helicobacter pylori-related gastroenterology studies (11 papers). Fengbin Liu collaborates with scholars based in China, Hong Kong and Australia. Fengbin Liu's co-authors include Xinlin Chen, Zhengkun Hou, Qiuke Hou, Yongquan Huang, Peiwu Li, Yi Wen, Mei Zhang, Changrong Zhang, Jiqian Fang and Li Zhao and has published in prestigious journals such as BMC Bioinformatics, Medicine and Oncotarget.

In The Last Decade

Fengbin Liu

52 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengbin Liu China 15 243 230 224 121 109 53 807
Zhengkun Hou China 11 162 0.7× 142 0.6× 150 0.7× 84 0.7× 106 1.0× 34 531
Weihong Sha China 17 345 1.4× 161 0.7× 137 0.6× 102 0.8× 133 1.2× 65 1.0k
Jiaming Qian China 19 282 1.2× 335 1.5× 152 0.7× 208 1.7× 55 0.5× 75 1.1k
Stephen R. Morley United Kingdom 16 100 0.4× 223 1.0× 139 0.6× 122 1.0× 48 0.4× 38 756
S. D. Lee Taiwan 13 133 0.5× 216 0.9× 159 0.7× 191 1.6× 32 0.3× 28 810
Haojie Yang China 19 327 1.3× 95 0.4× 36 0.2× 129 1.1× 238 2.2× 51 802
Gina Gheorghe Romania 11 134 0.6× 120 0.5× 62 0.3× 115 1.0× 53 0.5× 48 588
Christopher Leung United States 15 506 2.1× 184 0.8× 79 0.4× 800 6.6× 67 0.6× 36 1.4k
Aleksandar Nagorni Serbia 11 75 0.3× 148 0.6× 71 0.3× 143 1.2× 28 0.3× 57 567

Countries citing papers authored by Fengbin Liu

Since Specialization
Citations

This map shows the geographic impact of Fengbin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengbin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengbin Liu more than expected).

Fields of papers citing papers by Fengbin Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengbin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengbin Liu. The network helps show where Fengbin Liu may publish in the future.

Co-authorship network of co-authors of Fengbin Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Fengbin Liu. A scholar is included among the top collaborators of Fengbin Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengbin Liu. Fengbin Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Xiaotao, et al.. (2025). Eleutheroside A inhibits PI3K/AKT1/mTOR-mediated glycolysis in MDSCs to alleviate their immunosuppressive function in gastric cancer. International Immunopharmacology. 159. 114907–114907. 2 indexed citations
2.
3.
4.
Zhang, Mei, et al.. (2021). Dietary and Lifestyle Factors Related to Gastroesophageal Reflux Disease: A Systematic Review. Therapeutics and Clinical Risk Management. Volume 17. 305–323. 81 indexed citations
5.
Liu, Fengbin, et al.. (2020). A Methodological and Reporting Quality Assessment of Systematic Reviews/Meta-Analyses about Chinese Medical Treatment for Gastroesophageal Reflux Disease. Gastroenterology Research and Practice. 2020. 1–19. 5 indexed citations
6.
Hou, Zhengkun, et al.. (2020). Quantifying Liver‐Stomach Disharmony Pattern of Functional Dyspepsia Using Multidimensional Analysis Methods. Evidence-based Complementary and Alternative Medicine. 2020(1). 2562080–2562080. 3 indexed citations
7.
Zhang, Changrong, Yongquan Huang, Peiwu Li, et al.. (2020). Ginger relieves intestinal hypersensitivity of diarrhea predominant irritable bowel syndrome by inhibiting proinflammatory reaction. BMC Complementary Medicine and Therapies. 20(1). 279–279. 30 indexed citations
8.
9.
Chen, Xu, et al.. (2019). Efficacy of traditional Chinese Medicine for gastric precancerous lesion: A meta-analysis of randomized controlled trials. Complementary Therapies in Clinical Practice. 38. 101075–101075. 3 indexed citations
10.
Hou, Qiuke, et al.. (2019). Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-κB and notch signalling pathways. BMC Complementary and Alternative Medicine. 19(1). 337–337. 31 indexed citations
11.
Chen, Xinlin, Yi Wen, Beiping Zhang, et al.. (2018). Development of a Traditional Chinese Medicine Syndrome‐Specific Scale for Ulcerative Colitis: The Large Intestine Dampness‐Heat Syndrome Questionnaire. Evidence-based Complementary and Alternative Medicine. 2018(1). 4039019–4039019. 13 indexed citations
12.
Jiang, Xiaotao, et al.. (2018). Berberine Combined with Triple Therapy versus Triple Therapy for Helicobacter pylori Eradication: A Meta‐Analysis of Randomized Controlled Trials. Evidence-based Complementary and Alternative Medicine. 2018(1). 8716910–8716910. 7 indexed citations
13.
Hou, Zhengkun, et al.. (2018). [Inspirations of Rome Ⅳ on clinical evaluation of traditional Chinese medicine for functional gastrointestinal disease].. PubMed. 43(10). 2168–2176. 1 indexed citations
14.
Hou, Zhengkun, et al.. (2018). Quantifying Liver Stagnation Spleen Deficiency Pattern for Diarrhea Predominate Irritable Bowel Syndromes Using Multidimensional Analysis Methods. Evidence-based Complementary and Alternative Medicine. 2018(1). 6467135–6467135. 8 indexed citations
15.
Hou, Zhengkun, et al.. (2017). Interpreting the Chinese version of quality of life questionnaire for functional digestive disorders. Journal of Gastroenterology and Hepatology. 33(4). 869–877. 7 indexed citations
16.
Hou, Qiuke, Yongquan Huang, Peiwu Li, et al.. (2017). MiR-144 Increases Intestinal Permeability in IBS-D Rats by Targeting OCLN and ZO1. Cellular Physiology and Biochemistry. 44(6). 2256–2268. 67 indexed citations
17.
Mi, Hong, Linda L. D. Zhong, Tao Huang, et al.. (2017). Chineseherbalmedicineforulcerativecolitis:asystematicreview protocol. World Journal of Traditional Chinese Medicine. 3(2). 16–19. 1 indexed citations
18.
Chen, Xinlin, et al.. (2017). Inflammatory bowel disease-specific health-related quality of life instruments: a systematic review of measurement properties. Health and Quality of Life Outcomes. 15(1). 177–177. 72 indexed citations
19.
Chen, Xinlin, et al.. (2017). Prognostic value of transforming growth factor-beta in patients with colorectal cancer who undergo surgery: a meta-analysis. BMC Cancer. 17(1). 240–240. 37 indexed citations
20.
Liu, Fengbin, et al.. (2000). The Development of Syndrome Differential Scale of the Spleen-stomach Diseases Used for Computer Aided Expert Diagnosis System. Journal of Sun Yat-sen University. 21. 112. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhengkun Hou Breakdown of academic impact, for papers by Weihong Sha Breakdown of academic impact, for papers by Jiaming Qian Breakdown of academic impact, for papers by Stephen R. Morley Breakdown of academic impact, for papers by S. D. Lee Breakdown of academic impact, for papers by Haojie Yang Breakdown of academic impact, for papers by Gina Gheorghe Breakdown of academic impact, for papers by Christopher Leung Breakdown of academic impact, for papers by Aleksandar Nagorni
Rankless by CCL
2026